My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Board of Sundaram Finance approve demerger of non-financial services investment into wholly owned subsidiary
Feb 17,2017

The Board of Directors of Sundaram Finance has on 17 February 2017 approved a proposal to demerge the non-financial services investment of Sundaram Finance into wholly owned subsidiary, Sundaram Finance Investments. Following the demerger, Sundaram Finance Investments would be listed on the stock exchanges, subject to necessary approvals from regulators and shareholders.

Powered by Capital Market - Live News

Rural Electrification Corporation gets included in Nifty 100 and Nifty Next 50 indices
Feb 17,2017

Rural Electrification Corporation announced that as per the press release issued by India Index Services & Products (IISL) who manages a portfolio of 67 indices under NIFTY brand as of 30 September 2016 including NIFTY 50 and it is a group Company of National Stock Exchange of India, the Index Maintenance Sub-Committee (IMSC) of IISL in its Meeting held on 16 February 2017 has inter-alia decided to include Rural Electrification Corporation in NIFTY 100 and NIFTY Next 50 with effect from 31 March 2017. The above inclusion is based on various qualifying factors and good performance of the stock of REC.

Powered by Capital Market - Live News

Vaibhav Global allots 1,791 equity shares
Feb 17,2017

Vaibhav Global has allotted 1,791 Equity Shares of Rs. 10 each on 17 February 2017 to Vaibhav Global Employee Stock Option Welfare Trust under VGL Employee Stock Option Plan (As Amended) - 2006.

Consequent to the said allotment, the paid up Equity Share Capital of the Company has increased to Rs. 32,54,56,170 consisting of 3,25,45,617 Equity Shares of Rs. 10 each.

Powered by Capital Market - Live News

Inditrade Capital intimates of hike in stake in Inditrade Business Consultants
Feb 17,2017

Inditrade Capital announced that Inditrade Business Consultants has allotted 60,00,000 (Sixty lakh) equity shares at a face value of Rs. 10/- (Rupees Ten only) each to the Company on 17 February 2017 and consequently the present equity shareholding of the Company in Inditrade Business Consultants has become 99.8%.

Powered by Capital Market - Live News

Moschip Semiconductor Technology secures contract valued USD 1 million
Feb 17,2017

Moschip Semiconductor Technology announced that its US subsidiary has entered into an agreement with one of its partners in the US to produce and support a custom silicon solution for its digital cinema product. The value of this contract is nearly USD 1 million to be executed during the next two quarters.

Powered by Capital Market - Live News

Richway International Trade to hold board meeting
Feb 17,2017

Richway International Trade will hold a meeting of the Board of Directors of the Company on 22 February 2017, to consider Proposal of Delisting of the Equity Shares of the Company from BSE Institutional Trading Platform (ITP).

Powered by Capital Market - Live News

Sai Moh Auto Links to hold board meeting
Feb 17,2017

Sai Moh Auto Links will hold a meeting of the Board of Directors of the Company on 22 February 2017, to consider and appoint some Directors on the Board of the Company.

Powered by Capital Market - Live News

Board of Sundaram Finance recommends dividend
Feb 17,2017

Sundaram Finance announced that the Board of Directors of the Company at its meeting held on 17 February 2017, inter alia, have recommended the dividend of Rs 5 per equity Share (i.e. 50%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Mangalam Drugs and Organics provides update on audit of Unit 2
Feb 17,2017

Mangalam Drugs and Organics announced that the Company facility at Unit-2 was recently audited by WHO- Geneva and we have been issued few procedural observations. Further the Company shall respond to the same within stipulated time after the receipt of Audit Report. The Company believe that the audit was successful.

Powered by Capital Market - Live News

Venus Remedies to hold board meeting
Feb 17,2017

Venus Remedies will hold a meeting of the Board of Directors of the Company on 22 February 2017, to consider and approve raising of funds by way of Qualified Institutional Placement (QIP).

Powered by Capital Market - Live News

Board of Modison Metals recommends dividend
Feb 17,2017

Modison Metals announced that the Board of Directors of the Company at its meeting held on 17 February 2017, inter alia, have recommended the dividend of Rs 1 per equity Share (i.e. 100%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

HCL Technologies named Leader for Life Sciences IT Application Services
Feb 17,2017

HCL Technologies continues to be recognized for its global leadership in life sciences IT services and solutions. Everest Group, in its report Life Sciences IT Application Services - Service Provider Landscape with PEAK MatrixTM Assessment 2016n++ named HCL among leaders, recognizing HCLs wide range of application services solutions across all value chain elements of life sciences practice.

Powered by Capital Market - Live News

Fredun Pharmaceuticals to hold board meeting
Feb 17,2017

Fredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 24 February 2017, to discuss, consider and approve the matter of the Increasing Authorised Capital of the Company.

Powered by Capital Market - Live News

Central Bank of India announces appointment of director
Feb 17,2017

Central Bank of India announced that in terms of Government of India, Ministry of Finance Notification dated 16 February 2017, P. Ramana Murthy, General Manager of Allahabad Bank has been appointed as Executive Director of the Bank for a period of 3 years w.e.f. the date of his taking over charge of the post i.e. 17 February 2017, or until further orders, whichever is earlier.

Powered by Capital Market - Live News

Cipla launches adult Hepatitis B vaccine
Feb 17,2017

Cipla has launched adult Hepatitis B vaccine in India. Under a co-exclusive agreement with Serum Institute of India (SII), Cipla will market the vaccine for adults while SII will market it for adults and children.

Powered by Capital Market - Live News